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Abstract We report a young woman with sudden and
severe retroorbital headache, neck pain, and a large sellar
mass extending to the suprasellar cistern. A presumptive
diagnosis of non-secreting pituitary macroadenoma under-
going apoplexy was made and transphenoidal surgery per-
formed. Histopathology revealed mononuclear inﬁltration
and marked non-hemorrhagic necrosis of the anterior pitu-
itary consistent with a diagnosis of necrotizing infundibulo-
hypophysitis. The possible pathogenesis of this rare variant
of hypophysitis is discussed.
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Introduction
Necrosis results from several types of insults and presents
with morphologically distinct patterns. In the anterior
pituitary, necrosis is usually of vascular origin and more
often associated with pituitary adenomas (Table 1). It is
found at surgery or during pathological examination of the
resected sellar mass [3], often accompanied by hemor-
rhages (hemorrhagic necrosis). In a minority of cases, it
develops so rapidly and extensively that it causes a sudden
increase in the size of the pituitary gland accompanied by
symptoms such as headache, visual disturbances, ophthal-
moplegia, nausea, vomiting, and altered mental status, an
emergency condition known as pituitary apoplexy. Pitui-
tary necrosis is also typical of Sheehan syndrome. It is an
ischemic necrosis resulting from the hypotension that
ensues after severe uterine bleeding at the time of delivery
[4]. It typically results in gradual hypopituitarism that may
remain unrecognized for years; however, a few patients
may develop acute pituitary apoplexy.
In very rare cases, necrosis is observed in hypophysitis,
a chronic inﬂammation of the pituitary gland that com-
prises two more common forms, lymphocytic and granu-
lomatous, and two rarer forms, xanthomatous and IgG4
plasmacytic [1, 2]. In these forms, necrosis is typically
limited to small areas and does not dominate the histopa-
thological picture [2]. In 1993, however, Ahmed and
colleagues described 2 patients with a ﬁfth pathological
variant they called necrotizing infundibulo-hypophysitis
[3]. They reported two young men with central diabetes
insipidus, partial hypopituitarism, and MRI features sug-
gestive of hypophysitis (enlarged anterior pituitary and
thickened stalk) who underwent pituitary surgery. Analysis
of the resected tissue showed extensive necrosis sur-
rounded by a lympho-plasmacytic inﬁltration and ﬁbrosis,
with only scattered areas of glandular tissue remaining.
A third case was reported in the Japanese literature
in a 14 year-old boy with a prolonged history of diabetes
insipidus, but the diagnosis of necrotizing infundibulo-
neurohypophysitis was established without pituitary
biopsy, so its classiﬁcation remains uncertain [4].
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DOI 10.1007/s11102-011-0307-2We report here the third case of biopsy-proven necro-
tizing infundibulo-hypophysitis in a young woman who
presented with severe headache and secondary amenorrhea
and was carefully followed up for 1 year after pituitary
surgery.
Case report
A 20 year-old woman with a three-year history of migraine
and secondary amenorrhea suddenly developed severe
retroorbital headache and neck pain. Physical examination
and visual acuity were normal. Visual ﬁelds could not be
assessed because headache rendered the ophthalmic
perimetry intolerable, despite sufﬁcient analgesic coverage.
Magnetic resonance imaging (MRI) revealed a 22 9
20 9 16 mm pituitary mass with slight suprasellar exten-
sion (Fig. 1). The pituitary mass was iso- to hyperintense
on T2- (Fig. 1a) and hyperintense on T1-weighted images
(Fig. 1b). The typical posterior pituitary bright spot was
absent (Fig. 1d). After i.v. contrast (gadolinium), only
slight to moderate and inhomogeneous enhancement
occurred, most pronounced in the periphery of the mass
(Fig. 1c). The pituitary stalk and infundibulum were
slightly thickened and showed avid enhancement (Fig. 1e).
Assessment of pituitary function revealed increased
prolactin and secondary hypogonadism (Table 2). Thyroid,
adrenal, and growth hormone axes were normal. A
Table 1 Etiology of pituitary necrosis
Tumorous Pituitary adenoma
Pituitary metastases
Ischemic Sheehan syndrome
Thrombotic/
Hypercoagulative
Antepartum necrosis of gestational diabetes
Septic shock
Autoimmune Hypophysitis
Mechanical Elevated intracranial pressure (secondary to
subarachnoidal hemorrhage, basilar artery
thrombosis)
Miscellaneous Pituitary stimulation test
Spinal anesthesia
Snake venom poisoning
Fig. 1 Magnetic resonance imaging before surgery. The 22 9
20 9 16 mm pituitary mass is iso- to hyperintense on T2 with
suprasellar extension (a) and hyperintense in T1-weighted, non-
enhanced images. The typical posterior pituitary bright spot is absent
(d). After i.v. contrast (c), only slight to moderate and inhomogeneous
enhancement occurs, most pronounced at the periphery of the mass.
The pituitary stalk and infundibulum are slightly thickened showing
avid enhancement (d)
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123diagnosis of non-secreting macroadenoma with pituitary
apoplexy was established based on clinical ﬁndings and
imaging. The patient was started on hydrocortisone
(40 mg/day) and prepared for surgery. A transseptal
transsphenoidal surgical approach to the pituitary was
performed 2 days after the onset of headaches.
Opening of the sella revealed no hemorrhage but rather
a ﬂeshy, gum-like mass intimately connected with a rub-
bery pituitary. The components of the gland that appeared
pathological were completely removed. The remaining
gland was inspected extensively and showed no other areas
suggestive of tumor or hemorrhage.
Pathological evaluation of the excised tissue revealed no
adenoma. The key feature was instead an abundance of
necrotic tissue with only small areas of anterior and pos-
terior pituitary remaining. These areas were heavily inﬁl-
trated by mononuclear cells (Fig. 3a, b), with abundant
CD8-positive cytotoxic T cells in both anterior (Fig. 3c, d)
and posterior pituitary (Fig. 3e, f). The remaining anterior
pituitary showed acini of secretory cells surrounded by a
reticulin-rich network. Single cells were positive when
stained for the different hormones (ACTH, GH, TSH, FSH,
LH, PRL). Small areas of the posterior pituitary showed
regular pituicytes with partial expression of glial ﬁbrillary
acidic protein (GFAP).
After surgery the patient developed diabetes insipidus,
which was treated with desmopressin replacement, as well
asadynamiadespite hydrocortisonetherapy. At the 3 month
follow-up, the headaches had ceased, the initial hormonal
defects (hyperprolactinemia and secondary hypogonadism)
persisted (Table 2), the diabetes insipidus was controlled by
desmopressin (spray every 16 h), and a secondary adrenal
insufﬁciency was detected by an ACTH stimulation test
(serum cortisol measured after intravenous 250 lgo f
ACTH) (Table 2). Six months after surgery, normoprolac-
tinemia was seen under estradiol substitution, but decreased
free thyroxine (7.4 ng/l) and inappropriately normal TSH
values (0.5 mU/l) indicated the appearance of secondary
hypothyroidism, and decreased IGF-1 levels (98 lg/l) a
concomitant growth hormone deﬁciency. Adynamia
improved after initiation of thyroxine replacement (50 lg/
day) and continuation of hydrocortisone (then 20 mg/day).
Overall this progression to panhypopituitarism suggested
that, despite surgical removal of the inﬂamed and necrotic
pituitary mass, the remaining pituitary parenchyma was still
targeted by the autoimmune attack. Up to the present, the
patient has not been affected by other autoimmune diseases.
Control cranial MRI were performed 6 and 9 months
after surgery. At 6 months, the anterior pituitary and the
stalk appeared normal in size (Fig. 2a), but there was still
no normal T1 hyperintense signal in the posterior pituitary
(Fig. 2c). A 4 9 7 9 6 mm sized cyst was also found in
the left sellar region. After administration of gadolinium
(Fig. 2b), the remaining anterior pituitary and stalk were
Table 2 Endocrinological characteristics before and after pituitary surgery
Hormone Reference value Method 2 days
before surgery
3 months
after surgery
6 months
after surgery
Prolactin 91–552 mU/l ECLIA 628 1,955 108
LH 0.8–8.3 mU/ml ECLIA 0.7 0.6 0.6
a
FSH 1.2–10.1 mU/ml ECLIA 0.52 0.8 1.0
a
Estradiol 30–330 pg/ml ECLIA \7.0 \7.0 116.8
a
TSH 0.45–3.20 mU/l ECLIA 0.87 3.81 0.50
fT3 2.4–4.4 ng/l ECLIA 2.9 2.9 2.5
fT4 8.9–17.0 ng/l ECLIA 12.7 9.5 7.4
ACTH 7.2–63.3 lg/l ECLIA 10.3 6.9 \1.0
b
Cortisol (baseline) 5–25 lg/dl ECLIA 72 84
c 415
b
Cortisol (30 min after 250 lg ACTH) [30 lg/dl ECLIA nm 112 nm
Cortisol (60 min after 250 lg ACTH) [70 lg/dl ECLIA nm 137 nm
GH \6.88 lg/l CLA 1.1 nm nm
IGF-1 108–247 lg/l CLA nm 156 98
nm: not measured
ECLIA: electrochemiluminescencs assay (Roche Diagnostics, Mannheim, Germany)
CLIA: chemiluminescens immuno assay (DiaSorin, Dietzenbach, Germany)
Italics within this table are used for pathological values
a Under estradiol substitution
a,b Under hydrocortisone substitution
c Two days after discontinuing hydrocortisone
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123physiologically enhanced but no enhancement of the in-
trasellar cyst was observed. At 9 months, the anterior
pituitary and stalk maintained their normal size and
enhanced normally (Fig. 2d–f). The physiologic posterior
pituitary bright spot in non-enhanced T1 images was still
lacking (data not shown), and the left intrasellar cyst had
disappeared.
Discussion
We describe a case of hypophysitis with inﬂammatory
inﬁltration of the anterior and posterior pituitary and partial
necrosis of the anterior pituitary, consistent with the
diagnosis of necrotizing infundibulo-hypophysitis. This
condition is extremely rare; only 3 cases have been pre-
viously reported, diagnosed in two patients [3], and sus-
pected in a third [4]. The diagnosis of necrotizing
infundibulo-hypophysitis is based solely on pathological
examination of the resected pituitary since the clinical
presentation and the MRI appearance do not differ from
other more common forms of hypophysitis. The more
common forms of hypophysitis are lymphocytic, granu-
lomatous and xanthomatous [1]. Patients with necrotizing
infundibulo-hypophysitis present acutely with sudden and
severe headache and develop a complete and long-lasting
hypopituitarism, features that can, however, be seen in
other non-secreting pituitary masses [5]. MRI reveals
symmetrical enlargement of the pituitary gland without
signs of hemorrhage, as well as a thickened, pathologically
enhancing stalk, features that again are not speciﬁc enough
to establish a diagnosis before pituitary surgery. Conﬁr-
mation of the diagnosis of necrotizing infundibulo-
hypophysitis, as in other forms of hypophysitis, requires
the pathological examination of the surgically removed
pituitary specimen.
The key diagnostic feature of necrotizing infundibulo-
hypophysitis is a marked mononuclear inﬁltrate within
pituitary tissue showing signiﬁcant necrosis. Pituitary
necrosis can be found in various conditions (Table 1), most
commonly in adenomas with apoplexy [6, 7] and Sheehan
syndrome [8, 9]. Pituitary necrosis is also seen in gesta-
tional diabetes mellitus [10], hypophysitis, and sporadi-
cally after pituitary stimulation tests [11], spinal anesthesia
[12], or snake poisoning [13]. In routine autopsy series,
pituitary necrosis is found in about 10% of cases without
neoplasms [14]. In the majority of published series on
pituitary apoplexy, no differentiation is made between pure
infarction or infarction with hemorrhage, and very few
cases of pituitary apoplexy due to pure infarction have
Fig. 2 Magnetic resonance imaging at 6 and 9 months after surgery.
Six months after surgery, MRI revealed a left intrasellar cyst of
4 9 7 9 6m m( a) with normal-appearing anterior pituitary and
pituitary stalk, not enhancing after gadolinium (b). There is still no
normal T1 hyperintense signal of the posterior pituitary (c). Nine
months after surgery MRI demonstrates a normal anterior pituitary
and pituitary stalk with normal enhancement (d–f), but the normal
posterior pituitary bright spot in non-enhanced T1 images is still
lacking (not shown)
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123therefore been described [7, 15–18]. In cases with pituitary
adenoma apoplexy, a peripheral rim enhancement is seen
in those cases in which the interval between symptom onset
and surgery constituted several weeks to months [18].
Pathologically, the enhancing rim corresponds to prolifer-
ating connective tissue, mononuclear cell inﬁltration, and
atrophic endocrine cells at the edge of the infarction or
hemorrhage. In general, however, pituitary necrosis is not
accompanied by the marked lymphocytic inﬁltration seen
in patients with infundibulo-neurohypophysitis, suggesting
an autoimmune pathogenesis for this form.
Necrosis and apoptosis are tightly linked with autoim-
munity. Apoptosis is a form of programmed cell death
during which the cell order is dismantled, usually with
fragmentation and release of apoptotic bodies. During this
process the cytoplasmic membrane rearranges but remains
intact so that no inﬂammatory reaction is elicited. The
rearranged cell surface allows the binding of numerous
factors such as the complement factor C1q [19] and the
milk factor globule epidermal growth factor 8 [20] that
suppress inﬂammation and promote the engulfment by
macrophages and dendritic cells [21]. However, if the
apoptotic cell is not removed promptly and efﬁciently, it
progresses to a state of secondary necrosis in which the
cytoplasmic membrane is eventually disrupted. The cell
then becomes pro-inﬂammatory rather than immunosup-
pressive, capable of activating dendritic cells and lym-
phocytes [22]. In fact, failed removal of apoptotic cells is
known to be associated with autoimmunity in both mice
and humans [23]. The mechanisms through which an
incompletely removed apoptotic cell favors initiation and
propagation of an autoimmune response remain to be elu-
cidated. Autoantigens may reach unusually high concen-
trations in apoptotic bodies or undergo post-translational
modiﬁcations that make them better recognizable by the
immune system. The pro-inﬂammatory environment can
also lead to expression of class II MHC molecules on cells.
In fact, pituitary cells are able to synthetize MHC class II
molecules in experimental settings [24] as well as in
patients with lymphocytic hypophysitis [1], which makes
these cells ideally capable of interacting with activated
immunocompetent cells. Moreover, experimental evidence
Fig. 3 Necrosis and T cell
inﬂammation of pituitary.
Anterior pituitary shows partial
necrosis (a,H E940) with
inﬁltration by numerous
macrophages (b, KiM1P 940).
Necrotic areas in the upper part
are marked by arrows. T cell
inﬁltrates with high numbers of
cytotoxic T cells are found in
the anterior pituitary (c,
CD3 940, and d, CD8 940) as
well as posterior pituitary (e,
CD3 940 and f, CD8 940).
Original magniﬁcation: a,
b 910, c–f 920. Scale bar
100 lm
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123suggests that not only neoplastic but also normal pituitary
can support an inﬂammatory reaction via expression of
multiple cytokines, including IL-1, IL-1 receptor agonist,
IL-2, and IL-6 [25]. In pituitary necrosis, these cytokines
may serve as an abnormal stimulant that elicits systemic or
local inﬂammation, which can induce hypophysitis in the
neighboring, residual normal gland. The small number of
reported patients with necrotizing hypophysitis and the
absence of an animal model speciﬁc for this pathological
variant make it difﬁcult to draw any conclusions.
Another possible scenario is the spontaneous develop-
ment of pituitary necrosis that is without recognizable
precipitating events as previously described [26]. Such a
scenario seems unlikely in our young patient particularly
since the necrosis was associated with lymphocytic inﬁl-
tration of the remaining anterior and even posterior pitui-
tary. We therefore think that the necrosis was secondary to
the inﬂamed and enlarged pituitary gland, which is in
keeping with the observation that the patient suffered from
secondary hypogonadism for 3 years. After the gonado-
tropin insufﬁciency, our patient developed corticotropin,
thyrotropin and growth hormone deﬁciency as well as
diabetes insipidus. However, a spontaneous reduction in
the size of her pituitary gland after surgical biopsy, along
with a normal-appearing anterior pituitary and infundibu-
lum, was demonstrated in consecutive MR control images.
The posterior pituitary bright spot still did not reappear.
Deﬁciency of the anterior and posterior pituitary function
in our patient might be explained by ongoing autoimmune
destruction of the gland. This autoimmune reaction is
either primary, as would be the case in autoimmune
hypophysitis preceding pituitary apoplexy, or secondary, as
necrosis of the pituitary is known to initiate the liberation
of autoantigens from the damaged cells, triggering sec-
ondary autoimmune process through pituitary autoanti-
bodies [27]. The latter can not be proven in our case, as no
pituitary antibodies were measured in our patient.
In conclusion, we report a young woman with diabetes
insipidus and hypopituitarism, demonstrating a character-
istic MRI appearance with symmetrical gland enlargement,
loss of posterior pituitary bright spot, thickening and
pathological enhancement of the pituitary stalk and
infundibulum, as is usually seen in autoimmune hypophy-
sitis [28]. Histopathology showed massive pituitary, non-
hemorrhagic necrosis and lymphocytic inﬁltration of the
normal-appearing anterior and posterior pituitary, as
reported in two previously published cases of necrotizing
infundibulo-hypophysitis [3]. The pathogenesis of this rare
hypophysitis variant remains unknown.
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